Skip to main content
. 2020 Jun 30;2020:5120230. doi: 10.1155/2020/5120230

Figure 3.

Figure 3

Compounds used in the treatment of hyperkinetic movement disorders related to HD (12) and used to slow down the progression of ALS (13 and 14).